Konvertitur transkonfinali
NACE-BEL 2025 21209 → ekwivalenti CAE Rev 4 (Portugal)
Il-klassifikazzjoni nazzjonali tal-attivitajiet ta' Belgium (NACE-BEL 2025) taqsam l-istruttura ta' 4 ċifri tagħha mal-istandard UE NACE Rev 2.1. Fuq din il-bażi, nuru s-subklassi(jiet) ekwivalenti CAE Rev 4 użati f'Portugal.
Klassi ġenitur UE kondiviża
21.20
Manufacture of pharmaceutical preparations
This class includes: - manufacture of medicaments: • antisera and other blood fractions • vaccines • diverse medicaments, including homeopathic preparations - manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments - manufacture of medical diagnostic preparations, including pregnancy tests - manufacture of radioactive in-vivo diagnostic substances - manufacture of cell and gene advance therapy medical products This class also includes: - manufacture of medical impregnated wadding, gauze, bandages, dressings, etc. - preparation of botanical products (grinding, grading, milling) for pharmaceutical use - manufacture of viral vector-based medicines or vaccines - manufacture of pharmaceutical preparations for veterinary medicines This class excludes: - manufacture of herb infusions (mint, vervain, chamomile, etc.), see 10.83 - manufacture of probiotics, see 21.10 - manufacture of dental fillings and dental cement, see 32.50 - manufacture of bone reconstruction cements, see 32.50 - manufacture of surgical drapes, see 32.50 - wholesale of pharmaceuticals, see 46.46 - retail sale of pharmaceuticals, see 47.73 - research and development for pharmaceuticals and other biotech products, see 72.10 - packaging of pharmaceuticals, see 82.92
21209
Manufacture of other pharmaceutical products
21201
Fabricação de medicamentos
Compreende a fabricação de medicamentos alopáticos, homeopáticos e outros medicamentos de origem natural, para medicina humana e veterinária.
21202
Fabricação de outras preparações e de artigos farmacêuticos
Compreende a fabricação de preparações farmacêuticas, com exceção dos medicamentos, tais como: soros imunizantes e vacinas, incluindo de vetor viral; contracetivos; reagentes destinados à determinação dos grupos ou dos fatores sanguíneos; preparações opacificantes para exames radiográficos; substâncias radioativas para diagnóstico ¿in-vivo¿; reagentes de diagnóstico para aplicação no paciente.
Dwar din il-konverżjoni
NACE-BEL 2025 hija l-klassifikazzjoni tal-attivitajiet użata f'Belgium. CAE Rev 4 hija s-sistema ekwivalenti f'Portugal. It-tnejn huma implimentazzjonijiet nazzjonali tal-UE NACE Rev 2.1, għalhekk kwalunkwe subklassi ta' 5 ċifri f'sistema waħda tista' tiġi traċċjata lura għal klassi UE ta' 4 ċifri kondiviża — u minn hemm, projettata fis-subklassijiet tal-pajjiż l-ieħor.
Din il-paġna hija ġġenerata għall-mistoqsija „NACE-BEL 2025 21209 għal CAE Rev 4” u tibqa' sinkronizzata mas-sinkronizzazzjoni Market Intelligence ta' kull xahar.